Sector pending / Miscellaneous Chemical ProductsUpdated 2026-05-10 22:07 UTC

NSE/BIOPOL stock hub

NSE/BIOPOL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/BIOPOLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/BIOPOL

In the news

Latest news · NSE/BIOPOL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E10.4

P25 n/aP50 n/aP75 n/a

ROE28.3

P25 n/aP50 n/aP75 n/a

ROIC25.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/BIOPOL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

137

Groups with data

Currency

INR

Showing 137 of 137 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Enterprise value	INR 1.3B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Miscellaneous Chemical Products
Last refreshed	2026-05-10
Market cap	INR 1.2B
Price	INR 112
Price currency	INR
Sic	2890
Symbol	nse/BIOPOL
Website	https://www.biopolchemicals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.41%
EV Earnings	14.38x
EV/EBIT	9.51x
EV/EBITDA	9.44x
EV/FCF	-4.79x
EV/Sales	1.59x
FCF yield	-22.26%
P/B ratio	2.43x
P/E ratio	10.35x
P/S ratio	1.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.69%
EBITDA Margin	16.81%
Gross margin	22.45%
Gross Profit	INR 182.7M
Net Income	INR 89.7M
Pretax Margin	14.82%
Profit Margin	11.03%
ROA	16.76
ROCE	24.67
ROE	28.29
ROIC	25.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	65.63x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 1.61
Assets	INR 697.8M
Cash	INR 5.2M
Current Assets	INR 550.2M
Current Liabilities	INR 147.3M
Debt	INR 84.6M
Debt EBITDA	INR 0.62
Debt Equity	INR 0.17
Debt FCF	INR -0.31
Equity	INR 499.2M
Interest Coverage	8.93
Liabilities	INR 198.5M
Long Term Assets	INR 147.6M
Long Term Liabilities	INR 51.2M
Net Cash	INR -79.5M
Net Cash By Market Cap	INR -6.56
Net Debt EBITDA	INR 0.58
Net Debt Equity	INR 0.16
Tangible Book Value	INR 499.2M
Tangible Book Value Per Share	INR 53.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.73
Inventory Turnover	4.02
Net Working Capital	INR 431.8M
Quick ratio	1.92
Working Capital	INR 402.9M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	101.9
All Time High	123.2
All Time High Change	-9.01%
All Time High Date	2026-05-04
All Time Low	84.75
All Time Low Change	32.27%
All Time Low Date	2026-03-02
ATR	7.91
Beta1y	0.52
High	114.5
High52	123.2
High52 Date	2026-05-04
High52ch	-9.01%
Low	109
Low52	84.75
Low52 Date	2026-03-02
Low52ch	32.27%
Ma50ch	10.02%
RSI	53.64
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	0.71x
Sortino ratio	1.21
Tr1m	13.23%
Tr1w	-3.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 135.8M
Operating margin	16.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,894,800%
Net Borrowing	7,796,000
Shares Insiders	67.66%
Shares Out	10,805,400

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -269.7M
Average Volume	90,600x
Bv Per Share	53.04
CAPEX	INR -142M
Ch1m	13.23
Ch1w	-3.15
Change	0.99%
Change From Open	0.72
Close	111
Days Gap	0.27
Depreciation Amortization	983,000
Dollar Volume	4,304,640
Earnings Date	2026-04-30
EBIT	INR 135.8M
EBITDA	INR 136.8M
EPS	INR 10.83
F Score	2
FCF	INR -269.7M
FCF EV Yield	-20.89x
FCF Per Share	INR -24.96
Financing CF	266,658,000
Fiscal Year End	March
Founded	2,023
Graham Number	113.68364
Graham Upside	1.41
Income Tax	INR 30.8M
Investing CF	-145,298,000
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Ma20	110.6
Ma20ch	1.38%
Net CF	-6,299,000
Next Earnings Date	2026-07-22
Open	111.3
Position In Range	56.36
Ppne	143,584,000
Price Date	2026-05-08
Price EBITDA	INR 8.86
Ptbv Ratio	2.43
Relative Volume	0.42x
Revenue	813,716,000x
Tax By Revenue	3.79x
Tax Rate	25.58%
Volume	38,400

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/BIOPOL pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns NSE/BIOPOL?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+67.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

NSE/BIOPOL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.6

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/BIOPOL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/BIOPOL stock rating?

nse/BIOPOL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/BIOPOL analysis?

The full report lives at /stocks/nse/BIOPOL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/BIOPOL?

The latest report frames nse/BIOPOL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/BIOPOL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.